Skin longevity beauty startup LNGVTY has secured ₹5 crore in seed funding led by Rukam Capital. The company plans to use the capital to boost its direct-to-consumer marketing, expand its product range, and invest in research. This move comes as the Indian skincare sector shifts toward science-backed and clinically validated products.
LNGVTY, a skincare startup focused on the science of skin longevity, has raised ₹5 crore in a seed funding round led by Rukam Capital. This investment marks a significant step for the brand as it seeks to strengthen its footprint in the competitive Indian beauty and personal care market. The funding also included participation from several angel investors.
Strategic Use of Capital
The company intends to utilize this fresh capital to support its next phase of growth. A key focus area for the brand is scaling its direct-to-consumer marketing efforts to reach a wider customer base. Beyond marketing, the company plans to use the funds to diversify its product portfolio, which is centered on the biological aspect of skin health. Additionally, the brand is prioritizing investment in research and innovation to ensure its product offerings remain aligned with its scientific approach. Strengthening the core founding team is also part of the plan to manage these expansion efforts effectively.
Evolving Skincare Market
The investment arrives during a period of transition in the Indian skincare industry. According to industry estimates, the Indian skincare market is seeing a notable shift as consumers move toward products that emphasize long-term dermatological benefits over basic cosmetic appeal. The market is projected to see significant growth in the coming years, driven by a rise in consumer awareness and a preference for products that are clinically tested.
For investors, the primary monitorable will be the company's ability to balance its expansion and marketing spending with sustainable customer acquisition costs. As a relatively new and early-stage entity, LNGVTY faces the common challenge of establishing brand loyalty in a sector dominated by both large, established multinational corporations and a growing number of niche, digitally native competitors. The company's future performance will depend on its ability to scale its operations while maintaining the product differentiation promised by its biology-first approach. Investors may track the company’s product launches and its ability to capture market share within the premium, science-backed skincare category.